论文部分内容阅读
目的：观察谷胱甘肽辅助治疗病毒性肝炎的疗效。方法：谷胱甘肽组４０例（男性３７例，女性３例；年龄４１±ｓ１０ａ）在综合治疗的基础上加用谷胱甘肽０．６～１．２ｇ溶于１０％葡萄糖注射液２５０ｍＬ中静脉滴注，ｑｄ，连用３０～６０ｄ；并与４２例（男性３３例，女性９例；年龄４２±９ａ）综合疗法（对照组）进行比较。结果：谷胱甘肽组和对照组的显效率分别是６２％和４３％，总有效率分别为８０％和５５％。谷胱甘肽组疗效明显优于对照组（Ｐ＜０．０５），且无副作用。结论：谷胱甘肽能作病毒性肝炎的辅助治疗
Objective: To observe the efficacy of glutathione-assisted treatment of viral hepatitis. Methods: Forty patients (37 males and 3 females; age 41 ± s10a) were treated with glutathione 0.6-1.2 g dissolved in 250 mL of 10% glucose injection on the basis of comprehensive treatment The patients were given intravenous drip (qd) for 30-60 days, and were compared with 42 patients (33 males, 9 females and 42 ± 9 years old) (control group). Results: The effective rates of glutathione group and control group were 62% and 43%, respectively. The total effective rates were 80% and 55% respectively. Glutathione group was significantly better than the control group (P <0.05), and no side effects. Conclusion: Glutathione can be adjuvant therapy for viral hepatitis